Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Parallel Session 3410

Update on Progressive Supranuclear Palsy and Related Tauopathies

Sunday, September 29, 2024
15:00 - 17:00 | Meeting Room 113 AB, Ground Level
Clinical, Translational

In this session, the faculty will demonstrate the clinical and pathological spectrum of PSP and related tauopathies and present current biomarkers and clinical trials in these disorders.

Irene Litvan, USA
Huw Morris, United Kingdom


Subtypes, Neuropathology, and Progression Patterns
Shelley Forrest, Australia

Tau-Based Biomarkers
Guenter Hoeglinger, Germany

Clinical Trials
Adam Boxer, USA

CSPC Liaisons:
Gabor Kovacs, Canada

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Describe the phenotypic and neuropathological spectrum of PSP and related tauopathies
  2. Identify neuroimaging and peripheral biomarkers of tauopathies
  3. Identify the targets for tau-based therapies and summarize current therapy trials

Recommended Audience
Fellow / Resident / Student
Researcher / Basic Science

Education Level
Beginner / Foundational
Experienced / Intermediate
Expert / Advanced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice